“…A number of fatty acid indices considered important for human health outcomes were calculated. The arachidonic acid (C20:4n-6) to eicosapentaenoic acid (C20:5n-3, ARA:EPA) ratio indicates the relative availability of precursors for PGF 2α and PGE 2 , respectively (Gulliver et al, 2013); the DHA de ciency index (DHADI), calculated from the ratio of C22:5n-6 to C22:4n-6, which indicates a relative de cit of DHA accompanied by an increased conversion of C22:4n-6 to C22:5n-6 (Neuringer et al, 1986, van den Ham et al, 2001; the DHA Su ciency Index (DHASI), calculated from the ratio of C22:6n-3 to C22:5n-6, which indicates a relative de ciency of DHA relative to the longest LCn-6PUFA DPAn-6 (Hoffman and Uauy, 1992, Hornstra and De Vriese, 2003); the PUFA to SFA ratio (P:S Ratio) which indicates a relative abundance of healthy fatty acids and reduced risk of CVD (Singer et al, 1986) and the Essential Fatty Acid Status Index (EFI), calculated from the ratio of (n-3 PUFA + n-6 PUFA) to (n-7 MUFA + n-9 MUFA) which indicates a relative availability of essential fatty acids (Al et al, 1995, de Groot et al, 2004, Hornstra et al, 1992. In addition, the ratio of C18:2n-6 (LA) to C18:3n-3 (ALA) was also determined (LA:ALA).…”